Boise (Meridian), Idaho

Principal Investigator
Mark Turner, MD, began his secondary education at Stanford University in California and completed his medical degree at Oral Roberts School of Medicine, Oklahoma. For the past 21 years, he has been the Principal Investigator for Velocity Clinical Research’s Boise (formerly Advanced Clinical Research of Meridian, Idaho) location. He has diverse research experience in subjects such as attention deficit/hyperactivity disorder, Alzheimer’s disease, pediatric and adult vaccines, diabetic neuropathy, and chronic obstructive pulmonary disease. Dr. Turner is also a Clinic Physician and Medical Director of both Northwest Neurobehavioral Health of Meridian, Idaho, and Warm Springs Counseling Center of Boise, Idaho, as well as a Clinic Physician at McMillan Urgent Care and Family Practice of Boise, Idaho.

Principal Investigator
Marian Shaw, MD began her secondary education at Austin College of Sherman, Texas, and received her Doctor of Medicine degree from University of Texas. She is board certified in Internal Medicine and Pulmonology. As a Principal Investigator, Dr. Shaw has overseen studies involving influenza, attention deficient/hyperactivity disorder, chronic idiopathic constipation, rheumatoid arthritis, bone mineral density, Alzheimer’s disease, symptomatic gout and elevated blood uric acid, rheumatoid arthritis, polycystic ovary syndrome, Alzheimer’s disease, and migraine.

Site Operations Manager
Laura Crenshaw earned her BA in Mass Communication and Journalism, with a Minor in Marketing from Boise State University. Needing a full-time job in the mass economic recession of 2008 she agreed to come work as a patient recruiter for clinical research, knowing nothing of the industry, but eager and willing to use her “gift of gab” to help market Advanced Clinical Research in the community. Not knowing the full career path and opportunities that lie ahead she spent 5 years recruiting patients into hundreds of vaccine and chronic studies, then moved into adhering to FDA regulations for the site as a Regulatory Specialist for another 5 years. With her in-depth knowledge of the industry and having worked 10 years for the company she advanced to Business Development to help continue building connections with sponsors and CRO’s to bring new therapeutic areas to the site. After successfully navigating these areas of research she became the Site Operations Manager in April 2021 under Velocity Clinical Research. Laura loves helping problem solve and tackle day-to-day operations to help drive Velocity’s success.